A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease

by He, D., Meng, D., Su, Y., Wang, J., Wang, X., Ye, H.
Published 2021

Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C

by Diaby, V., Jiang, X., Lo-Ciganic, W., Park, H., Parker, R., Vouri, S.M
Published 2021

Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores

by Cheng, J., Huang, R., Huang, S., Li, C., Li, M., Li, Y., Liu, J., Liu, L., Wang, J., Wu, C., Xue, L., Xue, R., Yao, R., Zhao, H., Zhao, X.-A, Zhu, C., Zhu, L.
Published 2021

Intravital Microscopy for the Study of Hepatic Glucose Uptake

by Kang, S.W.S, Porat-Shliom, N., Stefkovich, M.L
Published 2021

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population

by Bi, Y., Gu, Z., He, G., Liu, B.-C, Niu, W., Ren, D., Yuan, F., Yuan, R., Zhang, L.
Published 2022

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease...

by Anstee, Q.M, Avery, L., Dombrowski, S.U, Hallsworth, K., McPherson, S.
Published 2021

Prevalence of Fatty Liver Disease is Driven by Prediabetes and Diabetes: US NHANES 2017–2018

by Claypool, K., Patel, C.J
Published 2022

Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease

by Hagström, H., Ludvigsson, J.F, Röckert Tjernberg, A., Roelstraete, B., Sharma, R., Simon, T.G, Söderling, J., Thiele, M.
Published 2022

Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

by Dolan, R.D, Jirapinyo, P., McCarty, T.R, Shah, R., Thompson, C.C
Published 2022

Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design: NAFLD and Cardiovascular Disease

by Ferreira, J.P, Pellicori, P., Sanyal, A.J, Vaduganathan, M., Zannad, F.
Published 2022

The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications

by Bai, G.-H, Chen, S.-Y, Hsu, Y.-H, Lin, S.-C
Published 2022

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

by Anderson, J.E, Bakris, G.L, Ballantyne, C.M, Beckman, J.A, Bhatt, D.L, Bloomgarden, Z.T, Bozkurt, B., Budoff, M.J, Butler, J., Dagogo-Jack, S., de Boer, I.H, DeFronzo, R.A, Eckel, R.H, Einhorn, D., Fonseca, V.A, Green, J.B, Grunberger, G., Guerin, C., Handelsman, Y., Inzucchi, S.E, Jellinger, P.S, Kosiborod, M.N, Kushner, P., Lepor, N., Mende, C.W, Michos, E.D, Plutzky, J., Taub, P.R, Umpierrez, G.E, Vaduganathan, M., Weir, M.R
Published 2022

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients

by Akyildiz, M., Altay, O., Arif, M., Borén, J., Fredolini, C., Gonenli, M.G, Kim, W., Li, X., Mardinoglu, A., Nielsen, J., Saglam, B., Schwenk, J.M, Shoaie, S., Uhlén, M., Ural, D., Yang, H., Zeybel, M., Zhang, C.
Published 2021

Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity

by Cao, J., Dong, G., Fu, J., Huang, K., Wu, W., Xu, H., Ye, J., Zhang, J.
Published 2021

Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content

by Delany, J.P, Farhat, N., Jarnagin, J., Khalid, W.B, Kim, K., Lavery, L.
Published 2021

Low levels of spexin and adiponectin may predict insulin resistance in patients with non-alcoholic fatty liver

by Li, G., She, Y., Zhang, L., Zhang, Z.
Published 2021

Use of a convolutional neural network and quantitative ultrasound for diagnosis of fatty liver

by Do, M.N, Miller, R.J, Nguyen, T.N, Oelze, M.L, Park, T.H, Podkowa, A.S
Published 2021

Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study

by Gantzel, R.H, Grønbæk, H., Hansen, F.O, Muhammad, A.G, Pedersen, M.L, Rex, K.F, Villadsen, G.E
Published 2022

Advancing the global public health agenda for NAFLD: a consensus statement

by Åberg, F., Adams, L., Allen, A.M, Alnaser, F., Alqahtani, S.A, Alswat, K., Alvares-da-Silva, M.R, Alvaro, D., Andrade, R.J, Anstee, Q.M, Arab, J.P, Arrese, M., Awuku, Y.A, Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Batterham, R.L, Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C.D, Calleja, J.L, Carrieri, P., Carter, F., Castera, L., Castillo-Lopez, G., Castro-Narro, G.E, Chan, H.L.Y, Chan, W.-K, Chang, Y., Colombo, M., Coppell, K.J, Corey, K., Cortez-Pinto, H., Craxi, A., Crespo, J., Cryer, D., Cusi, K., Dassanayake, A., de Ledinghen, V., de Oliveira, C.P.M.S, DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Dirac, M.A, Dorairaj, P., Duseja, A., Ekstedt, M., El Kassas, M., Elsanousi, O.M, Esmat, G., Fan, J.-G, Farpour-Lambert, N., Fernandez, M.I.C, Figueroa, M.P, Flisiak, R., Fouad, Y., Francque, S., Fuchs, M., Gani, R.A, George, J., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G.B.-B, Grønbæk, H., Gulnara, A., Hagström, H., Hamid, S., Hebditch, V., Hickman, I.J, Hocking, S.L, Hofmann, W.P, Huang, T.T.-K, Hunyady, B., Idilman, R., Isakov, V.A, Iskandar, N.J, Ismail, M.H, Jamal, M.H, Jepsen, P., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H, Kaplan, L., Kautz, A., Kawaguchi, T., Khader, Y., Khatry, M.S.A, Kim, S.U, Kodjoh, N., Koek, G., Koike, K., Komas, N.P, Korenjak, M., Kugelmas, M., Labidi, A., Lange, N.F, Lavine, J.E, Lazarus, J.V, Lazo, M., Lee, N., Lesmana, C.R.A, Liu, C.-J, Long, M.T, Loomba, R., Lopez-Jaramillo, P., Macedo, M.P, Mahtab, M.A, Malekzadeh, R., Marchesini, G., Marinho, R., Mark, H.E, Martins, A.A.S, Mateva, L., Melin, P., Mikolasevic, I., Miller, V., Milovanovic, T., Murillo, O.A, Musso, C., Naamani, K.A, Nakajima, A., Nava, E., Nersesov, A.V, Newsome, P.N, Nikolova, D., Ninburg, M., Nlombi, C.M, Norris, S., Novak, K., Oben, J., Ocama, P., Ong, J.P, Onyekwere, C., Pan, C.Q, Papatheodoridis, G., Paruk, I., Patel, K., Penha-Gonçalves, C., Petta, S., Puri, P., Rac, M., Ralston, J., Ramji, A., Ratziu, V., Razavi, H., Rinella, M., Roberts, S., Roden, M., Romero, D., Romero-Gómez, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I.A, Sadirova, S., Salupere, R., Saparbu, T., Sarin, S.K, Sayegh, R., Schattenberg, J.M, Sebastiani, G., Seki, Y., Selmo, J., Serme, A.K, Shaw, J.E, Shawa, I.T, Shenoy, T., Sheriff, D.S, Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Song, M.J, Soriano, J., Spearman, C.W, Sridharan, K., Suárez, J.J, Sudhamshu, K.C, Sung, K.-C, Swain, M., Tacke, F., Taheri, S., Tan, S.-S, Tapper, E.B, the NAFLD Consensus Consortium, Thiele, M., Tolmane, I., Torres, E.A, Trauner, M., Treeprasertsuk, S., Tsochatzis, E.A, Turcanu, A., Valantinas, J., Valenti, L., Vázquez, S.E.M, Vesterhus, M., Waked, I., Wild, S.H, Willemse, J., Wong, R.J, Wong, V.W.-S, Xanthakos, S., Yilmaz, Y., Yki-Järvinen, H., Young, D.Y, Younossi, Z.M, Yu, M.-L, Zelber-Sagi, S., Zeybel, M., Zheng, K.I, Zheng, M.-H
Published 2022

Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity

by Bartsch, L.M, Bhatia, S.N, Bredella, M.A, Chung, R.T, Corey, K.E, Dichtel, L.E, Drescher, H.K, Gee, D.W, Gelrud, L., Gustafson, J.L, Hutter, M.M, Lauer, G.M, Masia, R., Meireles, O.R, Miller, K.K, Osganian, S.A, Rwema, S., Subudhi, S., Warren, A., Witkowski, E.R
Published 2022